KeyBanc Capital Markets increased its price target for Ventas (NYSE:VTR) to $90 from $85, maintaining an Overweight rating, following strong fourth-quarter results and positive 2026 guidance. The healthcare REIT is experiencing significant in-place rent growth of about 8% in its senior housing portfolio, alongside an improving supply and demand dynamic. Other firms like Goldman Sachs, Evercore ISI, and Cantor Fitzgerald also raised price targets or reiterated Buy/Overweight ratings, citing strong performance and future growth prospects.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
KeyBanc raises Ventas stock price target to $90 on strong rent growth
KeyBanc Capital Markets increased its price target for Ventas (NYSE:VTR) to $90 from $85, maintaining an Overweight rating, following strong fourth-quarter results and positive 2026 guidance. The healthcare REIT is experiencing significant in-place rent growth of about 8% in its senior housing portfolio, alongside an improving supply and demand dynamic. Other firms like Goldman Sachs, Evercore ISI, and Cantor Fitzgerald also raised price targets or reiterated Buy/Overweight ratings, citing strong performance and future growth prospects.